Skip to main content
Premium Trial:

Request an Annual Quote

20/20, Novartis Collaborate on Tumor Protein Profiling

NEW YORK, Oct. 9 - 20/20 GeneSystems said today it is collaborating with Novartis to identify protein expression and activation patterns in tumor samples.

 

Novartis will supply 20/20 with tissue samples for the company to evaluate with its Protein Function Identification Layered Membranes technology in order to build protein profiles that can be used to classify tumor subtypes, according to 20/20.

 

Novartis, which will have early access to 20/20 technology, will provide 20/20 with funding, though details were not disclosed.

 

20/20 GeneSystems is based in Rockville, Md.

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.